Brief Enhanced Anxiety Sensitivity Treatment for Anxiety

Phase-Based Progress Estimates
1
Effectiveness
1
Safety
Canandaigua VA Medical Center, Canandaigua, NY, Canandaigua, NY
Anxiety+3 More
Brief Enhanced Anxiety Sensitivity Treatment - Behavioral
Eligibility
18+
All Sexes
What conditions do you have?
Select

Study Summary

This pilot study trial will test the acceptability, feasibility, and usability of a brief enhanced anxiety sensitivity treatment to reduce anxiety sensitivity and functional impairment in Veterans.

Eligible Conditions

  • Anxiety
  • Functional Impairment

Treatment Effectiveness

Study Objectives

3 Primary · 5 Secondary · Reporting Duration: From baseline to follow-up (measured six weeks after intervention session)

From baseline to follow-up (measured six weeks after intervention session)
Mean change in depression
Mean changes in anxiety
Mean changes in avoidance due to the COVID-19 pandemic
Mean changes in functional impairment due to the COVID-19 pandemic
Mean changes in worry related to the COVID-19 pandemic
From baseline to post-intervention (two-weeks after virtual treatment session)
Mean change in Functional impairment
Mean change in anxiety sensitivity
Post-intervention (two weeks after virtual treatment session)
Program satisfaction

Trial Safety

Trial Design

1 Treatment Group

BEAST Condition
1 of 1
Experimental Treatment

15 Total Participants · 1 Treatment Group

Primary Treatment: Brief Enhanced Anxiety Sensitivity Treatment · No Placebo Group · N/A

BEAST Condition
Behavioral
Experimental Group · 1 Intervention: Brief Enhanced Anxiety Sensitivity Treatment · Intervention Types: Behavioral

Trial Logistics

Trial Timeline

Approximate Timeline
Screening: ~3 weeks
Treatment: Varies
Reporting: from baseline to follow-up (measured six weeks after intervention session)
Closest Location: Canandaigua VA Medical Center, Canandaigua, NY · Canandaigua, NY
Photo of new york 1Photo of new york 2Photo of new york 3
2016First Recorded Clinical Trial
0 TrialsResearching Anxiety
3 CompletedClinical Trials

Who is running the clinical trial?

VA Office of Research and DevelopmentLead Sponsor
1,459 Previous Clinical Trials
2,748,898 Total Patients Enrolled
16 Trials studying Anxiety
1,777 Patients Enrolled for Anxiety
Nicholas P Allan, PhDPrincipal InvestigatorCanandaigua VA Medical Center, Canandaigua, NY

Eligibility Criteria

Age 18+ · All Participants · 3 Total Inclusion Criteria

Mark “yes” if the following statements are true for you:
You have a score equal to or greater than 9 on the SSASI indicating elevated anxiety sensitivity.
You have a score equal to or greater than 5 on the WHODAS 2.0.

About The Reviewer

Michael Gill preview

Michael Gill - B. Sc.

First Published: October 9th, 2021

Last Reviewed: August 12th, 2022

Michael Gill holds a Bachelors of Science in Integrated Science and Mathematics from McMaster University. During his degree he devoted considerable time modeling the pharmacodynamics of promising drug candidates. Since then, he has leveraged this knowledge of the investigational new drug ecosystem to help his father navigate clinical trials for multiple myeloma, an experience which prompted him to co-found Power Life Sciences: a company that helps patients access randomized controlled trials.